Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 8/20 | 0.41 |
| ▸ | CTSA | P10619 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.34 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.34 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SMO | Q99835 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4022910 | 0.90 | LPAR1 (0.41) | LPAR1CTSALPAR2LPAR3GPBAR1 | |
| SCHEMBL4021242 | 0.90 | LPAR1 (0.41) | LPAR1CTSASMN1; SMN2LPAR2LPAR3 | |
| SCHEMBL4022155 | 0.89 | LPAR1 (0.47) | LPAR1LPAR2LPAR3MEN1KMT2A | |
| SCHEMBL4027626 | 0.88 | LPAR1 (0.44) | LPAR1LPAR2LPAR3MEN1KMT2A | |
| SCHEMBL4027629 | 0.87 | LPAR1 (0.39) | LPAR1SMN1; SMN2NPC1RAB9AKMT2A | |
| SCHEMBL4024811 | 0.87 | LPAR1 (0.47) | LPAR1LPAR2LPAR3MEN1KMT2A | |
| SCHEMBL4027632 | 0.87 | LPAR1 (0.39) | LPAR1SMN1; SMN2NPC1RAB9AKMT2A | |
| SCHEMBL4029400 | 0.80 | ALDH1A1 (0.43) | SMN1; SMN2MEN1KMT2AGPBAR1ALDH1A1 | |
| SCHEMBL4023164 | 0.77 | LPAR1 (0.39) | LPAR1SMN1; SMN2RAB9ALMNA | |
| SCHEMBL4034159 | 0.76 | LPAR1 (0.44) | LPAR1CTSASMN1; SMN2LPAR2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7517996-B2 | Azole compound | AJINOMOTO CO., INC. (JP) | 2009-04-14 | — | — | US | disclosed |
| US-20060194850-A1 | Novel azole compound | AJINOMOTO CO. INC (JP) | 2006-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060194850-A1 | Novel azole compound | LPAR1, LPAR2, LPAR3 | LPAR1 1/4885CTSA 1358/4885SMN1; SMN2 4589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.